JP2014532058A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532058A5
JP2014532058A5 JP2014533842A JP2014533842A JP2014532058A5 JP 2014532058 A5 JP2014532058 A5 JP 2014532058A5 JP 2014533842 A JP2014533842 A JP 2014533842A JP 2014533842 A JP2014533842 A JP 2014533842A JP 2014532058 A5 JP2014532058 A5 JP 2014532058A5
Authority
JP
Japan
Prior art keywords
compound
inert solvent
reacting
prepared
providing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014533842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532058A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/069303 external-priority patent/WO2013050310A1/en
Publication of JP2014532058A publication Critical patent/JP2014532058A/ja
Publication of JP2014532058A5 publication Critical patent/JP2014532058A5/ja
Pending legal-status Critical Current

Links

JP2014533842A 2011-10-04 2012-10-01 5−[2−[7−(トリフルオロメチル)−5−[4−(トリフルオロメチル)フェニル]ピラゾロ[1,5−a]ピリミジン−3−イル]エチニル]−2−ピリジンアミンの製造方法 Pending JP2014532058A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161542837P 2011-10-04 2011-10-04
US61/542,837 2011-10-04
US201261684181P 2012-08-17 2012-08-17
US61/684,181 2012-08-17
PCT/EP2012/069303 WO2013050310A1 (en) 2011-10-04 2012-10-01 Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine

Publications (2)

Publication Number Publication Date
JP2014532058A JP2014532058A (ja) 2014-12-04
JP2014532058A5 true JP2014532058A5 (enExample) 2015-11-19

Family

ID=46963723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014533842A Pending JP2014532058A (ja) 2011-10-04 2012-10-01 5−[2−[7−(トリフルオロメチル)−5−[4−(トリフルオロメチル)フェニル]ピラゾロ[1,5−a]ピリミジン−3−イル]エチニル]−2−ピリジンアミンの製造方法

Country Status (15)

Country Link
US (1) US9447099B2 (enExample)
EP (1) EP2763991B1 (enExample)
JP (1) JP2014532058A (enExample)
KR (1) KR20140071474A (enExample)
CN (1) CN103857679A (enExample)
AR (1) AR088098A1 (enExample)
AU (1) AU2012320732A1 (enExample)
BR (1) BR112014007850A2 (enExample)
CA (1) CA2847092A1 (enExample)
IL (1) IL231283A0 (enExample)
MX (1) MX2014004062A (enExample)
RU (1) RU2630700C2 (enExample)
SG (2) SG2014014203A (enExample)
WO (1) WO2013050310A1 (enExample)
ZA (1) ZA201401398B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016013711A (es) * 2014-04-23 2017-01-13 Hoffmann La Roche Antagonistas de receptores de glumato metabotropicos 2/3 (mglu2/3) para el tratamiento de varias discapacidades intelectuales.
CA3085001C (en) * 2019-05-20 2021-10-05 Mabplex International, Ltd. One-pot process for preparing intermediate of antibody-drug conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05013233A (es) 2003-06-12 2006-03-09 Hoffmann La Roche Derivados de imidazol heteroaril-substituidos como antagonistas del receptor de glutamato.
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
EP1725544B1 (en) * 2004-03-09 2009-05-27 Boehringer Ingelheim Pharmaceuticals Inc. 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
ATE512966T1 (de) * 2005-02-11 2011-07-15 Hoffmann La Roche Pyrazolo-pyrimidin-derivate als mglur2- antagonisten
PT1863818E (pt) * 2005-03-23 2010-04-09 Hoffmann La Roche Derivados de acetilenil-pirazolo-pirimidina como antagonistas de mglur2
ATE463495T1 (de) * 2005-09-27 2010-04-15 Hoffmann La Roche Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
EP2384328B1 (en) * 2008-11-27 2013-02-13 Boehringer Ingelheim International GmbH 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and process for preparing them
WO2011014520A2 (en) * 2009-07-29 2011-02-03 Irm Llc Compounds and compositions as modulators of gpr119 activity

Similar Documents

Publication Publication Date Title
JP2010095546A5 (enExample)
RU2012119550A (ru) Способы синтеза спиро-оксиндольных соединений
JP2010174033A5 (enExample)
JP2013032389A5 (enExample)
JP2009149903A5 (enExample)
JP2010512316A5 (enExample)
JP2013534205A5 (enExample)
JP2013532130A5 (enExample)
JP2011518833A5 (enExample)
JP2013102146A5 (ja) 化合物
EP4691557A3 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
JP2011057686A5 (enExample)
JP2013500371A5 (enExample)
JP2010501534A5 (enExample)
JP2009235096A5 (enExample)
JP2011227454A5 (enExample)
JP2014511367A5 (enExample)
JP2014500861A5 (enExample)
EP3444238A3 (en) Process for preparing difluoromethylene compounds
JP2012094862A5 (enExample)
JP2011511794A5 (ja) 塩の製造のための方法
JP2018507858A5 (enExample)
JP2014528463A5 (enExample)
JP2013040118A5 (enExample)
JP2016523246A5 (enExample)